ArticleInternational journal of clinical oncology2021

Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations.

Yasuhiro Kato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.